Genetic disorders of pigmentation

Clinics in Dermatology

Volumn 23, Issue 1, 2005, Pages 56-67

  Passeron, Thierry ^a   Mantoux, Frédéric ^b   Ortonne, Jean Paul ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBRIGHT SYNDROME; BIOGENESIS; CAFE AU LAIT SPOT; CHEDIAK HIGASHI SYNDROME; EMBRYO DEVELOPMENT; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; GENODERMATOSIS; GLIOMA; GRISCELLI SYNDROME; HUMAN; HYPERPIGMENTATION; HYPOMELANOSIS; HYPOPIGMENTATION; LENTIGINOSIS; LENTIGO; LEOPARD SYNDROME; LEUKEMIA; MELANOCYTE; MELANOGENESIS; MELANOSOME; MOSAICISM; MYXOMA; NEUROFIBROMATOSIS; NONHUMAN; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM; PATHOPHYSIOLOGY; PEUTZ JEGHERS SYNDROME; PHENOTYPE; PIEBALDISM; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKIN PIGMENTATION; TUBEROUS SCLEROSIS; TURCOT SYNDROME; VITILIGO; WAARDENBURG SYNDROME;

EID: 13644260560     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2004.09.013     Document Type: Review

References (97)

1. D.B. Mosher, and T.B. Fitzpatrick Piebaldism Arch. Dermatol. 124 1988 364 365
2. R.A. Spritz Piebaldism, Waardenburg syndrome, and related disorders of melanocyte development Semin. Cutan. Med. Surg. 16 1997 15 23
3. K. Jimbow, T.B. Fitzpatrick, G. Szabo, and Y. Hori Congenital circumscribed hypomelanosis: a characterization based on electron microscopic study of tuberous sclerosis, nevus depigmentosus, and piebaldism J. Invest. Dermatol. 64 1975 50 62
4. R.A. Fleischman, D.L. Saltman, and V. Stastny Deletion of the c-kit protooncogene in the human developmental defect piebald trait Proc. Natl. Acad. Sci. U. S. A. 88 1991 10885 10889
5. L.B. Giebel, and R.A. Spritz Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism Proc. Natl. Acad. Sci. U. S. A. 88 1991 8696 8699
6. K. Ezoe, S.A. Holmes, and L. Ho Novel mutations and deletions of the KIT (steel factor receptor) gene in human piebaldism Am. J. Hum. Genet. 56 1995 58 66
7. J. Grabbe, P. Welker, and E. Dippel Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes Arch. Dermatol. Res. 287 1994 78 84
8. S. Nishikawa, M. Kusakabe, and K. Yoshinaga In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development EMBO J. 10 1991 2111 2118
9. K.A. Ward, C. Moss, and D.S. Sanders Human piebaldism: relationship between phenotype and site of kit gene mutation Br. J. Dermatol. 132 1995 929 935
10. P. Raanani, J.M. Goldman, and I. Ben-Bassat Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571 J. Clin. Oncol. 20 2002 869 870
11. S. Hasan, K. Dinh, and F. Lombardo Hypopigmentation in an African patient treated with imatinib mesylate: a case report J. Natl. Med. Assoc. 95 2003 722 724
12. C. Robert, A. Spatz, and S. Faivre Tyrosine kinase inhibition and grey hair Lancet 361 2003 1056
13. M.J. Hageman, and J.W. Delleman Heterogeneity in Waardenburg syndrome Am. J. Hum. Genet. 29 1977 468 485
14. J.P. Ortonne Piebaldism, Waardenburg's syndrome, and related disorders. "Neural crest depigmentation syndromes"? Dermatol. Clin. 6 1988 205 216
15. X.Z. Liu, V.E. Newton, and A.P. Read Waardenburg syndrome type II: phenotypic findings and diagnostic criteria Am. J. Med. Genet. 55 1995 95 100
16. P. Kaplan, and J.P. de Chaderevian Piebaldism-Waardenburg syndrome: histopathologic evidence for a neural crest syndrome Am. J. Med. Genet. 31 1988 679 688
17. M. Tassabehji, A.P. Read, and V.E. Newton Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2 Nat. Genet. 3 1993 26 30
18. C.F. Hoth, A. Milunsky, and N. Lipsky Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I) Am. J. Hum. Genet. 52 1993 455 462
19. C.T. Baldwin, N.R. Lipsky, and C.F. Hoth Mutations in PAX3 associated with Waardenburg syndrome type I Hum. Mutat. 3 1994 205 211
20. C.T. Baldwin, C.F. Hoth, and R.A. Macina Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature Am. J. Med. Genet. 58 1995 115 122
21. B. Wollnik, T. Tukel, and O. Uyguner Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2 Am. J. Med. Genet. 122A 2003 42 45
22. M.D. Goulding, A. Lumsden, and P. Gruss Signals from the notochord and floor plate regulate the region-specific expression of two Pax genes in the developing spinal cord Development 117 1993 1001 1016
23. A. Watanabe, K. Takeda, and B. Ploplis Epistatic relationship between Waardenburg syndrome genes MITF and PAX3 mutations in PAX3 that cause Waardenburg syndrome type I ten new mutations and review of the literature mutations in PAX3 associated with Waardenburg syndrome type I mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I) Nat. Genet. 18 1998 283 286
24. G.G. McGill, M. Horstmann, and H.R. Widlund Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability Cell 109 2002 707 718
25. J.E. Reynolds, J.M. Meyer, and B. Landa Analysis of variability of clinical manifestations in Waardenburg syndrome Am. J. Med. Genet. 57 1995 540 547
26. A.E. Hughes, V.E. Newton, and X.Z. Liu A gene for Waardenburg syndrome type 2 maps close to the human homologue of the microphthalmia gene at chromosome 3p12-p14.1 Nat. Genet. 7 1994 509 512
27. Y. Nobukuni, A. Watanabe, and K. Takeda M. Tachibana Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A Am. J. Hum. Genet. 59 1996 76 83
28. A.P. Read, and V.E. Newton Waardenburg syndrome J. Med. Genet. 34 1997 656 665
29. M. Sanchez-Martin, A. Rodriguez-Garcia, and J. Perez-Losada SLUG (SNAI2) deletions in patients with Waardenburg disease Hum. Mol. Genet. 11 2002 3231 3236
30. K.N. Shah, S.J. Dalal, and M.P. Desai White forelock, pigmentary disorder of irides, and long segment Hirschsprung disease: possible variant of Waardenburg syndrome J. Pediatr. 99 1981 432 435
31. P. Edery, T. Attie, and J. Amiel Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome) Nat. Genet. 12 1996 442 444
32. A.S. McCallion, and A. Chakravarti EDNRB/EDN3 and Hirschsprung disease type II Pigment Cell Res. 14 2001 161 169
33. V. Pingault, N. Bondurand, and N. Lemort A heterozygous endothelin 3 mutation in Waardenburg-Hirschsprung disease: is there a dosage effect of EDN3/EDNRB gene mutations on neurocristopathy phenotypes? J. Med. Genet. 38 2001 205 209
34. V. Pingault, N. Bondurand, and K. Kuhlbrodt SOX10 mutations in patients with Waardenburg-Hirschsprung disease Nat. Genet. 18 1998 171 173
35. K.K. Chan, C.K. Wong, and V.C. Lui Analysis of SOX10 mutations identified in Waardenburg-Hirschsprung patients: differential effects on target gene regulation J. Cell. Biochem. 90 2003 573 585
36. C. Paratore, D.E. Goerich, and U. Suter Survival and glial fate acquisition of neural crest cells are regulated by an interplay between the transcription factor Sox10 and extrinsic combinatorial signaling Development 128 2001 3949 3961
37. D.E. Barton, B.S. Kwon, and U. Francke Human tyrosinase gene, mapped to chromosome 11 (q14-q21), defines second region of homology with mouse chromosome 7 Genomics 3 1988 17 24
38. W.S. Oetting, and R.A. King Molecular basis of albinism: mutations and polymorphisms of pigmentation genes associated with albinism Hum. Mutat. 13 1999 99 115
39. M.H. Brilliant The mouse p (pink-eyed dilution) and human P genes, oculocutaneous albinism type 2 (OCA2), and melanosomal pH Pigment Cell Res. 14 2001 86 93
40. K. Toyofuku, J.C. Valencia, and T. Kushimoto The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase Pigment Cell Res. 15 2002 217 224
41. C.D. Chintamaneni, M. Ramsay, and M.A. Colman Mapping the human CAS2 gene, the homologue of the mouse brown (b) locus, to human chromosome 9p22-pter Biochem. Biophys. Res. Commun. 178 1991 227 235
42. R.E. Boissy, and J.J. Nordlund Molecular basis of congenital hypopigmentary disorders in humans: a review Pigment Cell Res. 10 1997 12 24
43. T. Kobayashi, K. Urabe, and A. Winder Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis EMBO J. 13 1994 5818 5825
44. J.M. Newton, O. Cohen-Barak, and N. Hagiwara Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4 Am. J. Hum. Genet. 69 2001 981 988
45. B. Incerti, K. Cortese, and A. Pizzigoni Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1 Hum. Mol. Genet. 9 2000 2781 2788
46. J.P. Schachne, N. Glaser, and S.H. Lee Hermansky-Pudlak syndrome: case report and clinicopathologic review J. Am. Acad. Dermatol. 22 1990 926 932
47. C.J. Witkop, M. Krumwiede, and H. Sedano Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome Am. J. Hematol. 26 1987 305 311
48. J.A. Martina, K. Moriyama, and J.S. Bonifacino BLOC-3, a protein complex containing the Hermansky-Pudlak syndrome gene products HPS1 and HPS4 J. Biol. Chem. 278 2003 29376 29384
49. E.C. Dell'Angelica, V. Shotelersuk, and R.C. Aguilar Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor Mol. Cell 3 1999 11 21
50. M. Sugita, X. Cao, and G.F. Watts Failure of trafficking and antigen presentation by CD1 in AP-3-deficient cells Immunity 16 2002 697 706
51. T. Suzuki, W. Li, and Q. Zhang The gene mutated in cocoa mice, carrying a defect of organelle biogenesis, is a homologue of the human Hermansky-Pudlak syndrome-3 gene Genomics 78 2001 30 37
52. Q. Zhang, B. Zhao, and W. Li Ru2 and Ru encode mouse orthologs of the genes mutated in human Hermansky-Pudlak syndrome types 5 and 6 Nat. Genet. 33 2003 145 153
53. W. Li, Q. Zhang, and N. Oiso Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1) Nat. Genet. 35 2003 84 89
54. W. Faigle, G. Raposo, and D. Tenza Deficient peptide loading and MHC class II endosomal sorting in a human genetic immunodeficiency disease: the Chediak-Higashi syndrome J. Cell Biol. 141 1998 1121 1134
55. V.T. Tchernev, T.A. Mansfield, and L. Giot The Chediak-Higashi protein interacts with SNARE complex and signal transduction proteins Mol. Med. 8 2002 56 64
56. S.L. Rogers, R.L. Karcher, and J.T. Roland Regulation of melanosome movement in the cell cycle by reversible association with myosin V J. Cell Biol. 146 1999 1265 1276
57. P. Bahadoran, E. Aberdam, and F. Mantoux Rab27a: a key to melanosome transport in human melanocytes J. Cell Biol. 152 2001 843 850
58. G. Menasche, C.H. Ho, and O. Sanal Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1) J. Clin. Invest. 112 2003 450 456
59. A. Alkhateeb, G.L. Stetler, and W. Old Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2 Hum. Mol. Genet. 11 2002 661 667
60. P.R. Fain, K. Gowan, and G.S. LaBerge A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci Am. J. Hum. Genet. 72 2003 1560 1564
61. R.A. Spritz, K. Gowan, and D.C. Bennett Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis Am. J. Hum. Genet. 74 2004 188 191
62. S. Hurwitz, and I.M. Braverman White spots in tuberous sclerosis J. Pediatr. 77 1970 587 594
63. I. Gutman, D. Dunn, and M. Behrens Hypopigmented iris spot. An early sign of tuberous sclerosis Ophthalmology 89 1982 1155 1159
64. K.J. Awan Leaf-shaped lesions of ocular fundus and white eyelashes in tuberous sclerosis South. Med. J. 75 1982 227 228
65. M. van Slegtenhorst, R. de Hoogt, and C. Hermans Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 Science 277 1997 805 808
66. J.R. Sampson, and P.C. Harris The molecular genetics of tuberous sclerosis Hum. Mol. Genet. 3 Spec No. 1994 1477 1480
67. G. Benvenuto, S. Li, and S.J. Brown The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination Oncogene 19 2000 6306 6316
68. R. Ruiz-Maldonado, S. Toussaint, and L. Tamayo Hypomelanosis of Ito: diagnostic criteria and report of 41 cases Pediatr. Dermatol. 9 1992 1 10
69. E. Hatchwell Hypomelanosis of Ito and X;autosome translocations: a unifying hypothesis J. Med. Genet. 33 1996 177 183
70. W. Kuster, and A. Konig Hypomelanosis of Ito: no entity, but a cutaneous sign of mosaicism Am. J. Med. Genet. 85 1999 346 350
71. J.L. Bolognia, S.J. Orlow, and S.A. Glick Lines of Blaschko J. Am. Acad. Dermatol. 31 1994 157 190 [quiz 190-2]
72. K.S. Nehal, R. PeBenito, and S.J. Orlow Analysis of 54 cases of hypopigmentation and hyperpigmentation along the lines of Blaschko Arch. Dermatol. 132 1996 1167 1170
73. M. Upadhyaya, S.H. Roberts, and J. Maynard A cytogenetic deletion, del(17)(q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay J. Med. Genet. 33 1996 148 152
74. B. Streubel, E. Latta, and H. Kehrer-Sawatzki Somatic mosaicism of a greater than 1.7-Mb deletion of genomic DNA involving the entire NF1 gene as verified by FISH: further evidence for a contiguous gene syndrome in 17q11.2 Am. J. Med. Genet. 87 1999 12 16
75. J.E. DeClue, B.D. Cohen, and D.R. Lowy Identification and characterization of the neurofibromatosis type 1 protein product Proc. Natl. Acad. Sci. U. S. A. 88 1991 9914 9918
76. T.N. Basu, D.H. Gutmann, and J.A. Fletcher Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients Nature 356 1992 713 715
77. J. Griesser, D. Kaufmann, and B. Maier Post-transcriptional regulation of neurofibromin level in cultured human melanocytes in response to growth factors J. Invest. Dermatol. 108 1997 275 280
78. R. Busca, and R. Ballotti Cyclic AMP a key messenger in the regulation of skin pigmentation Pigment Cell Res. 13 2000 60 69
79. G.H. Watson Pulmonary stenosis, cafe-au-lait spots, and dull intelligence Arch. Dis. Child. 42 1967 303 307
80. M. Tassabehji, T. Strachan, and M. Sharland Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome Am. J. Hum. Genet. 53 1993 90 95
81. W.F. Schwindinger, C.A. Francomano, and M.A. Levine Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome Proc. Natl. Acad. Sci. U. S. A. 89 1992 5152 5156
82. T. Passeron, P. Bahadoran, and C. Bertolotto Cyclic AMP promotes a peripheral distribution of melanosomes and stimulates melanophilin/Slac2-a and actin association FASEB J. 18 2004 989 991
83. D. Whiteside, R. McLeod, and G. Graham A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots Cancer Res. 62 2002 359 362
84. A. Hemminki, P. Peltomaki, and J.P. Mecklin Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer Nat. Genet. 8 1994 405 410
85. S. Vilkki, J.L. Tsao, and A. Loukola Extensive somatic microsatellite mutations in normal human tissue Cancer Res. 61 2001 4541 4544
86. J. Turcot, J.P. Despres, and F. St. Pierre Malignant tumors of the central nervous system associated with familial polyposis of the colon: report of two cases Dis. Colon Rectum 2 1959 465 468
87. R.J. Gorlin, R.C. Anderson, and M. Blaw Multiple lentigines syndrome Am. J. Dis. Child. 117 1969 652 662
88. M.C. Digilio, E. Conti, and A. Sarkozy Grouping of multiple-lentigines/ LEOPARD and Noonan syndromes on the PTPN11 gene Am. J. Hum. Genet. 71 2002 389 394
89. C.A. Stratakis, L.S. Kirschner, and J.A. Carney Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation J. Clin. Endocrinol. Metab. 86 2001 4041 4046
90. H. Mehenni, J.L. Blouin, and U. Radhakrishna Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4 Am. J. Hum. Genet. 61 1997 1327 1334
91. D.E. Jenne, H. Reimann, and J. Nezu Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase Nat. Genet. 18 1998 38 43
92. S.B. Gruber, M.M. Entius, and G.M. Petersen Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome Cancer Res. 58 1998 5267 5270
93. K.G. Mountjoy, L.S. Robbins, and M.T. Mortrud The cloning of a family of genes that encode the melanocortin receptors Science 257 1992 1248 1251
94. H.B. Schioth, S.R. Phillips, and R. Rudzish Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair Biochem. Biophys. Res. Commun. 260 1999 488 491
95. M. Bastiaens, J. ter Huurne, and N. Gruis The melanocortin-1-receptor gene is the major freckle gene Hum. Mol. Genet. 10 2001 1701 1708
96. X.J. Zhang, P.P. He, and Y.H. Liang A gene for freckles maps to chromosome 4q32-q34 J. Invest. Dermatol. 122 2004 286 290
97. Y. Miyamura, T. Suzuki, and M. Kono Mutations of the RNA-specific adenosine deaminase gene (DSRAD) are involved in dyschromatosis symmetrica hereditaria Am. J. Hum. Genet. 73 2003 693 699